Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The window between leukapheresis and chimeric antigen receptor T cell (CAR T) infusion for relapsed or refractory large B cell lymphoma (R/R LBCL) represents a period of clinical vulnerability during which disease may progress, potentially compromising fitness for infusion and downstream outcomes.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.